eXoZymes, Inc.
EXOZ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 3.70 | -0.32 | 0.23 | -0.15 |
| FCF Yield | -1.55% | -1.92% | -1.33% | -4.41% |
| EV / EBITDA | -52.93 | -33.73 | -42.69 | -71.03 |
| Quality | ||||
| ROIC | -37.10% | -29.13% | -18.91% | -16.60% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.81 | 0.65 | 0.61 | 3.11 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -17.72% | -36.41% | 80.32% | -992.83% |
| Safety | ||||
| Net Debt / EBITDA | 1.71 | 2.44 | 3.82 | 4.71 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1,136.71 | -1,159.16 | -1,368.20 | -1,231.11 |